Results 11 to 20 of about 134,019 (273)
Staphylococcus aureus produces an antiphagocytic polysaccharide capsule to evade neutrophil-mediated killing. Many vaccines against encapsulated bacterial pathogens require generation of functional anti-capsular antibodies to mediate protection against ...
Ingrid L. Scully +5 more
doaj +2 more sources
Pneumococcal capsular polysaccharide structure predicts serotype prevalence. [PDF]
There are 91 known capsular serotypes of Streptococcus pneumoniae. The nasopharyngeal carriage prevalence of particular serotypes is relatively stable worldwide, but the host and bacterial factors that maintain these patterns are poorly understood. Given
Daniel M Weinberger +8 more
doaj +3 more sources
In vivo role of capsular polysaccharide in Mycoplasma mycoides [PDF]
Capsular polysaccharides have been confirmed to be an important virulence trait in many gram-positive and gram-negative bacteria. Similarly, they are proposed to be virulence traits in minimal Mycoplasma that cause disease in humans and animals.
Schieck, Elise G. +24 more
core +3 more sources
A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate [PDF]
Three important physical properties which may affect the performance of glycoconjugate vaccines against serious disease are molar mass (molecular weight), heterogeneity (polydispersity), and conformational flexibility in solution.
Harding, Stephen E. +15 more
core +1 more source
Heterologous expression of the pneumococcal serotype 14 polysaccharide in Lactococcus lactis requires lactococcal epsABC regulatory genes [PDF]
The pneumococcal serotype 14 polysaccharide was produced in Lactococcus lactis by coexpressing pneumococcal polysaccharide type 14-specific genes (cpsFGHIJKL(14)) with the lactococcal regulatory and priming glucosyltransferase-encoding genes specific for
Kleerebezem, M. +5 more
core +1 more source
Recombinant plants provide a new approach to the production of bacterial polysaccharide for vaccines. [PDF]
Bacterial polysaccharides have numerous clinical or industrial uses. Recombinant plants could offer the possibility of producing bacterial polysaccharides on a large scale and free of contaminating bacterial toxins and antigens.
G. C. Whitelam (7665758) +58 more
core +1 more source
Polysaccharide capsules are important virulence factors for many microbial pathogens including the opportunistic fungus Cryptococcus neoformans. In the present study, we demonstrate an unusual role for a secreted lactonohydrolase of C.
Yoon-Dong Park +13 more
doaj +1 more source
Staphylococcus aureusCapsular Polysaccharides [PDF]
SUMMARYSerotype 5 and 8 capsular polysaccharides predominate among clinical isolates ofStaphylococcus aureus.The results of experiments in animal models of infection have revealed that staphylococcal capsules are important in the pathogenesis ofS. aureusinfections.
Katherine, O'Riordan, Jean C, Lee
openaire +2 more sources
Bacterial capsular polysaccharides are important vaccine immunogens. However, the study of polysaccharide-specific immune responses has been hindered by technical restrictions.
Dennis Hoving +14 more
doaj +1 more source
ANTIGENICITY OF TYPE XII PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE IN RABBITS AND MICE.
ANTIGENICITY OF TYPE XII PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE IN RABBITS AND ...
PETER. BARAM (7974104)
core +4 more sources

